Concurrent Real-Time

Concurrent Real-Time company information, Employees & Contact Information

At Concurrent Real-Time, we’re proud to say we are the industry’s foremost provider of high-performance, real-time Linux computer systems and software solutions. Our core competencies include: Hardware-in-the-loop and man-in-the-loop simulation High-speed data acquisition and signal conditioning Process control solutions High-performance visual systems Low-latency transaction processing Our solutions are used in a wide range of markets including automotive, aerospace and defense, energy, transportation and finance. Our customers depend on us to help them reduce costs, simplify administration, speed time to market, maximize profits and lower risk. For more than 55 years, we have provided the best-in-class, real-time solutions and worldwide support for mission-critical applications. Concurrent Real-Time is part of HBK’s Virtual Test Division.
Looking for a particular Concurrent Real-Time employee's phone or email?

Concurrent Real-Time Questions

News

Concurrent Durvalumab Plus Chemo/RT Does Not Improve Efficacy in Stage III NSCLC - CancerNetwork

Concurrent Durvalumab Plus Chemo/RT Does Not Improve Efficacy in Stage III NSCLC CancerNetwork

Paola Anselmo: The Update of the STARTNEWERA Phase II Trial - Oncodaily

Paola Anselmo: The Update of the STARTNEWERA Phase II Trial Oncodaily

Greater Mortality Risk for Concurrent COPD and Arthritis - respiratory-therapy.com

Greater Mortality Risk for Concurrent COPD and Arthritis respiratory-therapy.com

Concurrent Real-Time's RedHawk Linux Earns Best-in-Show at 2024 NVIDIA GTC AI Conference and Expo - Embedded Computing Design

Concurrent Real-Time's RedHawk Linux Earns Best-in-Show at 2024 NVIDIA GTC AI Conference and Expo Embedded Computing Design

Concurrent Boost, Shorter RT Effective for High-Risk, Early Breast Cancer - Oncology News Central

Concurrent Boost, Shorter RT Effective for High-Risk, Early Breast Cancer Oncology News Central

A network meta-analysis for efficacies and toxicities of different concurrent chemoradiotherapy regimens in the treatment of locally advanced non-small cell lung cancer - BMC Cancer

A network meta-analysis for efficacies and toxicities of different concurrent chemoradiotherapy regimens in the treatment of locally advanced non-small cell lung cancer BMC Cancer

Concurrent/adjuvant ADT sequencing appears optimal in patients receiving prostate-only RT - Urology Times

Concurrent/adjuvant ADT sequencing appears optimal in patients receiving prostate-only RT Urology Times

Concurrent cisplatin and dose escalation with intensity-modulated radiotherapy (IMRT) versus conventional radiotherapy for locally advanced head and neck squamous cell carcinomas (HNSCC): GORTEC 2004-01 randomized phase III trial - ScienceDirect.com

Concurrent cisplatin and dose escalation with intensity-modulated radiotherapy (IMRT) versus conventional radiotherapy for locally advanced head and neck squamous cell carcinomas (HNSCC): GORTEC 2004-01 randomized phase III trial ScienceDirect.com

Concurrent Bevacizumab and Reirradiation vs Bevacizumab Alone in Recurrent Glioblastoma - The ASCO Post

Concurrent Bevacizumab and Reirradiation vs Bevacizumab Alone in Recurrent Glioblastoma The ASCO Post

One Cycle of Concurrent Chemotherapy vs. Two Cycles of Concurrent Chemotherapy With Radiation Therapy in Patients With Limited-Stage Small Cell Lung Cancer - Frontiers

One Cycle of Concurrent Chemotherapy vs. Two Cycles of Concurrent Chemotherapy With Radiation Therapy in Patients With Limited-Stage Small Cell Lung Cancer Frontiers

Radiotherapy combined with immunotherapy: the dawn of cancer treatment | Signal Transduction and Targeted Therapy - Nature

Radiotherapy combined with immunotherapy: the dawn of cancer treatment | Signal Transduction and Targeted Therapy Nature

Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and Neck - The New England Journal of Medicine

Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and Neck The New England Journal of Medicine

15 Concurrent Use of Abemaciclib and Radiation Therapy (RT) Among Patients With HR+, HER2– Metastatic Breast Cancer (MBC): Real-World Utilization and Safety - CancerNetwork

15 Concurrent Use of Abemaciclib and Radiation Therapy (RT) Among Patients With HR+, HER2– Metastatic Breast Cancer (MBC): Real-World Utilization and Safety CancerNetwork

Acute Cardiotoxicity With Concurrent Trastuzumab and Hypofractionated Radiation Therapy in Breast Cancer Patients - Frontiers

Acute Cardiotoxicity With Concurrent Trastuzumab and Hypofractionated Radiation Therapy in Breast Cancer Patients Frontiers

Fabio Arcidiacono: Update of the STARTNEWERA Phase II Trial - Oncodaily

Fabio Arcidiacono: Update of the STARTNEWERA Phase II Trial Oncodaily

Focused ultrasound-mediated blood–brain barrier opening is safe and feasible with moderately hypofractionated radiotherapy for brainstem diffuse midline glioma - Journal of Translational Medicine

Focused ultrasound-mediated blood–brain barrier opening is safe and feasible with moderately hypofractionated radiotherapy for brainstem diffuse midline glioma Journal of Translational Medicine

Neoadjuvant radiochemotherapy is safe and feasible for breast conserving surgery or immediate reconstruction - Nature

Neoadjuvant radiochemotherapy is safe and feasible for breast conserving surgery or immediate reconstruction Nature

Cardiac toxicity in patients with lung cancer receiving thoracic radiotherapy and immunotherapy - Frontiers

Cardiac toxicity in patients with lung cancer receiving thoracic radiotherapy and immunotherapy Frontiers

15 posts from ASTRO23 not to miss. - Oncodaily

15 posts from ASTRO23 not to miss. Oncodaily

Concurrent Tumor Treating Fields (TTFields) and Radiation Therapy for Newly Diagnosed Glioblastoma: A Prospective Safety and Feasibility Study - Frontiers

Concurrent Tumor Treating Fields (TTFields) and Radiation Therapy for Newly Diagnosed Glioblastoma: A Prospective Safety and Feasibility Study Frontiers

Radiotherapy combined with PD-1/PD-L1 inhibitors in NSCLC brain metastases treatment: The mechanisms, advances, opportunities, and challenges - Wiley Online Library

Radiotherapy combined with PD-1/PD-L1 inhibitors in NSCLC brain metastases treatment: The mechanisms, advances, opportunities, and challenges Wiley Online Library

Radiation combined with immune checkpoint inhibitors for unresectable locally advanced non-small cell lung cancer: synergistic mechanisms, current state, challenges, and orientations - Cell Communication and Signaling

Radiation combined with immune checkpoint inhibitors for unresectable locally advanced non-small cell lung cancer: synergistic mechanisms, current state, challenges, and orientations Cell Communication and Signaling

Five-year follow-up of the OptiTrain trial on concurrent resistance and high-intensity interval training during chemotherapy for patients with breast cancer | Scientific Reports - Nature

Five-year follow-up of the OptiTrain trial on concurrent resistance and high-intensity interval training during chemotherapy for patients with breast cancer | Scientific Reports Nature

Efficacy of concurrent radiotherapy in patients with locally advanced rectal cancer and synchronous metastasis receiving systemic therapy - Frontiers

Efficacy of concurrent radiotherapy in patients with locally advanced rectal cancer and synchronous metastasis receiving systemic therapy Frontiers

When Concurrent Chemoradiotherapy Makes Sense for Older Patients - Cleveland Clinic

When Concurrent Chemoradiotherapy Makes Sense for Older Patients Cleveland Clinic

Cetuximab's effectiveness and toxicity in advanced cutaneous squamous cell skin cancer - EurekAlert!

Cetuximab's effectiveness and toxicity in advanced cutaneous squamous cell skin cancer EurekAlert!

Regression Transformer enables concurrent sequence regression and generation for molecular language modelling - Nature

Regression Transformer enables concurrent sequence regression and generation for molecular language modelling Nature

Immunotherapy Combo Fails to Boost Survival in Limited-Disease SCLC - MedPage Today

Immunotherapy Combo Fails to Boost Survival in Limited-Disease SCLC MedPage Today

Safety of palbociclib concurrent with palliative pelvic radiotherapy: discussion of a case of increased toxicity and brief review of literature - Wiley Online Library

Safety of palbociclib concurrent with palliative pelvic radiotherapy: discussion of a case of increased toxicity and brief review of literature Wiley Online Library

Postoperative radiotherapy with docetaxel versus cisplatin for high-risk oral squamous cell carcinoma: a randomized phase II trial with exploratory analysis of ITGB1 as a potential predictive biomarker - BMC Medicine

Postoperative radiotherapy with docetaxel versus cisplatin for high-risk oral squamous cell carcinoma: a randomized phase II trial with exploratory analysis of ITGB1 as a potential predictive biomarker BMC Medicine

Head and neck small-cell carcinoma: A multicenter study of 39 cases from 10 institutions - Frontiers

Head and neck small-cell carcinoma: A multicenter study of 39 cases from 10 institutions Frontiers

Locally advanced head and neck squamous cell carcinoma treatment efficacy and safety: a systematic review and network meta-analysis - Frontiers

Locally advanced head and neck squamous cell carcinoma treatment efficacy and safety: a systematic review and network meta-analysis Frontiers

Upfront Radiotherapy with Concurrent and Adjuvant Vismodegib Is Effective and Well-Tolerated in a Patient with Advanced, Multifocal Basal Cell Carcinoma - Wiley Online Library

Upfront Radiotherapy with Concurrent and Adjuvant Vismodegib Is Effective and Well-Tolerated in a Patient with Advanced, Multifocal Basal Cell Carcinoma Wiley Online Library

PARP inhibitor radiosensitization enhances anti-PD-L1 immunotherapy through stabilizing chemokine mRNA in small cell lung cancer - Nature

PARP inhibitor radiosensitization enhances anti-PD-L1 immunotherapy through stabilizing chemokine mRNA in small cell lung cancer Nature

Exceptional response to chemotherapy followed by concurrent radiotherapy and immunotherapy in a male with primary retroperitoneal serous Adenocarcinoma: a case report and literature review - BMC Cancer

Exceptional response to chemotherapy followed by concurrent radiotherapy and immunotherapy in a male with primary retroperitoneal serous Adenocarcinoma: a case report and literature review BMC Cancer

The Effects of Concurrent Training Combining Both Resistance Exercise and High-Intensity Interval Training or Moderate-Intensity Continuous Training on Metabolic Syndrome - Frontiers

The Effects of Concurrent Training Combining Both Resistance Exercise and High-Intensity Interval Training or Moderate-Intensity Continuous Training on Metabolic Syndrome Frontiers

Can We Deintensify Treatment for Patients With Lower Risk HPV-Related Oropharyngeal Cancer? - Cleveland Clinic

Can We Deintensify Treatment for Patients With Lower Risk HPV-Related Oropharyngeal Cancer? Cleveland Clinic

Significance of concurrent use of weekly cisplatin in carbon-ion radiotherapy for locally advanced adenocarcinoma of the uterine cervix: A propensity score-matched analysis - Wiley Online Library

Significance of concurrent use of weekly cisplatin in carbon-ion radiotherapy for locally advanced adenocarcinoma of the uterine cervix: A propensity score-matched analysis Wiley Online Library

Concurrent or sequential adjuvant letrozole and radiotherapy after conservative surgery for early-stage breast cancer (CO-HO-RT): a phase 2 randomised trial - The Lancet

Concurrent or sequential adjuvant letrozole and radiotherapy after conservative surgery for early-stage breast cancer (CO-HO-RT): a phase 2 randomised trial The Lancet

Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck - The New England Journal of Medicine

Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck The New England Journal of Medicine

Nvidia RTX 30-Series Ampere Architecture Deep Dive: Everything We Know (Updated) - Tom's Hardware

Nvidia RTX 30-Series Ampere Architecture Deep Dive: Everything We Know (Updated) Tom's Hardware

Twice-Daily Compared with Once-Daily Thoracic Radiotherapy in Limited Small-Cell Lung Cancer Treated Concurrently with Cisplatin and Etoposide - The New England Journal of Medicine

Twice-Daily Compared with Once-Daily Thoracic Radiotherapy in Limited Small-Cell Lung Cancer Treated Concurrently with Cisplatin and Etoposide The New England Journal of Medicine

Top Concurrent Real-Time Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant